PHASE-II STUDY OF CARBOPLATIN AND CYTOSINE-ARABINOSIDE IN PATIENTS WITH DISSEMINATED MALIGNANT-MELANOMA

被引：5
|
作者：
MULDER, NH [1 ]
SLEIJFER, DT [1 ]
DEVRIES, EGE [1 ]
KOOPS, HS [1 ]
WILLEMSE, PHB [1 ]
机构：
[1] STATE UNIV GRONINGEN HOSP,DEPT SURG ONCOL,9713 EZ GRONINGEN,NETHERLANDS
来源：
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 1990年 / 116卷 / 03期
关键词：
Chemotherapy; Malignant melanoma;
D O I：
10.1007/BF01612907
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Twenty-one patients with disseminated malignant melanoma were treated with a combination of carboplatin and cytosine arabinoside. Two complete and three partial remissions occurred. No complete cross-resistance was found with a regimen containing 5-(dimethyltriazeno)imidazole-4-carboxamide (DTIC) in two patients. It is suggested that this regimen might be studied further as a second-line treatment for patients who fail on DTIC-containing treatment. © 1990 Springer-Verlag.
引用
收藏
页码：301 / 302
页数：2
相关论文
共 50 条
  • [41] PHASE-II EVALUATION OF L-ALANOSINE (NSC-153353) FOR PATIENTS WITH DISSEMINATED MALIGNANT-MELANOMA
    CREAGAN, ET
    LONG, HJ
    AHMANN, DL
    GREEN, SJ
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (05): : 543 - 544
  • [42] PHASE-II ASSESSMENT OF RECOMBINANT LEUKOCYTE-A INTERFERON WITH DIFLUOROMETHYLORNITHINE IN DISSEMINATED MALIGNANT-MELANOMA
    CREAGAN, ET
    LONG, HJ
    AHMANN, DL
    SCHAID, DJ
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (03): : 218 - 220
  • [43] PHASE-II STUDY OF LOW-DOSE RECOMBINANT LEUKOCYTE-A INTERFERON IN DISSEMINATED MALIGNANT-MELANOMA
    CREAGAN, ET
    AHMANN, DL
    GREEN, SJ
    LONG, HJ
    FRYTAK, S
    OFALLON, JR
    ITRI, LM
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (09) : 1002 - 1005
  • [44] PHASE-II TRIAL OF RECOMBINANT TUMOR-NECROSIS-FACTOR IN DISSEMINATED MALIGNANT-MELANOMA
    FELDMAN, ER
    CREAGAN, ET
    SCHAID, DJ
    AHMANN, DL
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (03): : 256 - 259
  • [45] PHASE-II STUDY - THE COMBINATION DTIC, BCNU, ACTINOMYCIN-D, AND VINCRISTINE IN DISSEMINATED MALIGNANT-MELANOMA
    CREAGAN, ET
    SCHUTT, AJ
    LONG, HJ
    GREEN, SJ
    MEDICAL AND PEDIATRIC ONCOLOGY, 1986, 14 (02): : 86 - 87
  • [46] A PHASE-II STUDY OF 5,6-DIHYDRO-5-AZACYTIDINE HYDROCHLORIDE IN DISSEMINATED MALIGNANT-MELANOMA
    CREAGAN, ET
    SCHAID, DJ
    HARTMANN, LC
    LOPRINZI, CL
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (03): : 243 - 244
  • [47] DISSEMINATED MALIGNANT-MELANOMA AND RECOMBINANT INTERFERON - ANALYSIS OF 7 CONSECUTIVE PHASE-II INVESTIGATIONS
    CREAGAN, ET
    SCHAID, DJ
    AHMANN, DL
    FRYTAK, S
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 95 (06) : S188 - S192
  • [48] PHASE-II STUDY OF RECOMBINANT LEUKOCYTE-A INTERFERON (RIFN-ALPHA-A) IN DISSEMINATED MALIGNANT-MELANOMA
    CREAGAN, ET
    AHMANN, DL
    GREEN, SJ
    LONG, HJ
    RUBIN, J
    SCHUTT, AJ
    DZIEWANOWSKI, ZE
    CANCER, 1984, 54 (12) : 2844 - 2849
  • [49] A PHASE-II STUDY OF CISPLATIN AND CYTOSINE-ARABINOSIDE FOR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    BERNSTEIN, JI
    JACOBS, C
    MEYERS, F
    RICHGOFFINET, L
    TANAKA, L
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (01): : 58 - 60
  • [50] PHASE-II STUDY OF ICRF-159 VERSUS COMBINATION CIS-DICHLORODIAMMINEPLATINUM(II) AND DTIC IN PATIENTS WITH DISSEMINATED MALIGNANT-MELANOMA
    AHMANN, DL
    EDMONSON, JH
    FRYTAK, S
    KVOLS, LK
    BISEL, HF
    RUBIN, J
    CANCER TREATMENT REPORTS, 1978, 62 (01): : 151 - 153
12345